Tissue-specific reprogramming of glutamine metabolism maintains tolerance to sepsis.
Reprogramming metabolism is of great therapeutic interest for reducing morbidity and mortality during sepsis-induced critical illness. Disappointing results from randomized controlled trials targeting glutamine and antioxidant metabolism in patients with sepsis have begged a deeper understanding of...
Main Authors: | Brooks P Leitner, Won D Lee, Wanling Zhu, Xinyi Zhang, Rafael C Gaspar, Zongyu Li, Joshua D Rabinowitz, Rachel J Perry |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2023-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0286525 |
Similar Items
-
Glutamine metabolic reprogramming in hepatocellular carcinoma
by: Yanyan Ye, et al.
Published: (2023-08-01) -
Neuromuscular Dysfunction in Experimental Sepsis and Glutamine
by: İlkin Çankayalı, et al.
Published: (2016-06-01) -
EFFECTS OF INTRAPERITONEAL GLUTAMINE IN THE TREATMENT OF EXPERIMENTAL SEPSIS
by: Emanuele Therezinha Schueda STONOGA, et al. -
Reprogramming of glutamine metabolism via glutamine synthetase silencing induces cisplatin resistance in A2780 ovarian cancer cells
by: Jing Guo, et al.
Published: (2021-02-01) -
T cell metabolic reprogramming in acute kidney injury and protection by glutamine blockade
by: Kyungho Lee, et al.
Published: (2023-06-01)